NeoGenomics is trading at $15.91 (+4.09%) during the live session, moving higher despite a lack of company-specific announcements or earnings catalysts.
- The upward move is consistent with a broader risk-on sentiment across U.S. equity markets, which typically lifts biotechnology names.
- Major indexes are providing a tailwind, with the Nasdaq Composite up 1.38% and the S&P 500 rising 1.00%.